Back to Markets
Stocks● Neutral
SOND Raises $7M for Dreambuds Sleep System
SOND emerges from stealth with $7M seed led by E14 Fund for Dreambuds, an in-ear sleep system with real-time sensing and AI guidance. Shipping later this year.
Continue with
SOND emerged from stealth Tuesday with $7 million in seed funding and the launch of Dreambuds, an in-ear sleep system that senses the body overnight and responds in real time.
The round was led by E14 Fund, the MIT-affiliated venture firm, with Crosslink Capital and Ubiquity Ventures participating. SOND is building Dreambuds as a hardware-plus-AI platform: the earbuds monitor biometric signals during sleep and adjust audio or other inputs to improve sleep quality. The company said the product uses real-time sensing and adaptive algorithms refined over two years of preclinical testing.
The MIT connection runs deeper than the lead investor. SOND's founding team includes engineers and sleep researchers with ties to the university's Media Lab and neuroscience programs. That academic grounding could give the startup an edge in clinical validation, a critical step for hardware in the health space.
Sleep technology has attracted growing venture interest as consumer awareness of sleep health rises. Oura rings, Eight Sleep mattresses, and Fitbit sleep tracking have normalized quantified rest. Most existing solutions are worn on the wrist or placed under the mattress. SOND's bet is that an in-ear form factor captures different signals – heart rate variability, body temperature, head movement – and delivers targeted feedback more precisely. The company says the ear canal also allows for core-body temperature measurement and potential brain-wave monitoring, though Dreambuds currently focus on audio-based feedback.
The $7 million seed round is modest by health-tech hardware standards. Hardware startups often require multiple rounds before generating revenue, and SOND will need to demonstrate product-market fit before a larger Series A. The company plans to use the capital to scale manufacturing and build out its software infrastructure for personalized sleep programs.
SOND joins a cohort of health-tech startups raising seed rounds at this scale. Earlier this year, Ladder Health closed a $7 million seed led by Nina Capital for its health platform. The parallel suggests venture investors are willing to place smaller bets on hardware-led health products, provided the team and technology show promise.
Dreambuds are expected to ship later this year. The company has not disclosed pricing. SOND is based in Boston.